Article Type
Changed
Mon, 04/15/2019 - 13:52
Display Headline
New treatment options for epilepsy
Article PDF
Author and Disclosure Information

Harold H. Morris III, MD
Head of the Section of Epilepsy and Sleep Disorders in the Department of Neurology at  Cleveland Clinic. His research interests involve the surgical treatment of refractory epilepsy and phase 3 clinical trials of antiepileptic drugs. He is a member of the American Epilepsy Society and an associate editor of the Journal of Clinical Neurophysiology.

Issue
Cleveland Clinic Journal of Medicine - 64(3)
Publications
Page Number
125-127
Sections
Author and Disclosure Information

Harold H. Morris III, MD
Head of the Section of Epilepsy and Sleep Disorders in the Department of Neurology at  Cleveland Clinic. His research interests involve the surgical treatment of refractory epilepsy and phase 3 clinical trials of antiepileptic drugs. He is a member of the American Epilepsy Society and an associate editor of the Journal of Clinical Neurophysiology.

Author and Disclosure Information

Harold H. Morris III, MD
Head of the Section of Epilepsy and Sleep Disorders in the Department of Neurology at  Cleveland Clinic. His research interests involve the surgical treatment of refractory epilepsy and phase 3 clinical trials of antiepileptic drugs. He is a member of the American Epilepsy Society and an associate editor of the Journal of Clinical Neurophysiology.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 64(3)
Issue
Cleveland Clinic Journal of Medicine - 64(3)
Page Number
125-127
Page Number
125-127
Publications
Publications
Article Type
Display Headline
New treatment options for epilepsy
Display Headline
New treatment options for epilepsy
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media